Mesenchymal Stem Cell Derived Biocompatible Membrane Vesicles Demonstrate Immunomodulatory Activity Inhibiting Activation and Proliferation of Human Mononuclear Cells

• Egile Nagusiak: Marina O. Gomzikova (Egilea), Sevindzh K. Kletukhina (Egilea), Sirina V. Kurbangaleeva (Egilea), Olga A. Neustroeva (Egilea), Olga S. Vasileva (Egilea), Ekaterina E. Garanina (Egilea), Svetlana F. Khaiboullina (Egilea), Albert A. Rizvanov (Egilea)
• Formatua: Liburua
• Argitaratua: MDPI AG, 2020-06-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Immune-mediated diseases are characterized by abnormal activity of the immune system. The cytochalasin B-induced membrane vesicles (CIMVs) are innovative therapeutic instruments. However, the immunomodulating activity of human mesenchymal stem cell (MSC)-derived CIMVs (CIMVs-MSCs) remains unknown. T...